Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Prisco

Showing results (71-80 of 261) with videos related to

Pageof 27
Sort By:
Annals of the Rheumatic Diseases|August 6, 2020
Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou <i>et al</i>Alessandra Bettiol, Francesca Pregnolato, Savino Sciascia, et al.
Internal and Emergency Medicine|May 10, 2023
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and CharybdisAlice Lipari, Silvia Sorrentino, Carlo Tamburini, et al.
Rheumatology (Oxford, England)|February 9, 2021
Comment on: Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. ReplyAlessandra Bettiol, Irene Mattioli, Giacomo Emmi, et al.
Thrombosis and Haemostasis|January 13, 2017
Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trialsFrancesco Dentali, Nicola Mumoli, Domenico Prisco, et al.
Thrombosis and Haemostasis|May 1, 2009
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatmentDaniela Poli, Emilia Antonucci, Elisa Grifoni, et al.
Seminars in Thrombosis and Hemostasis|September 30, 2009
Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: an Italian experienceDomenico Prisco, Emilia Antonucci, Elisa Grifoni, et al.
Blood Reviews|April 14, 2015
Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of researchAlessandro Di Minno, Gaia Spadarella, Domenico Prisco, et al.
Internal and Emergency Medicine|December 29, 2023
Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditisDanilo Malandrino, Federica Bello, Giuseppe Lopalco, et al.
Journal of Thrombosis and Thrombolysis|October 19, 2019
Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic strokeVieri Vannucchi, Federico Moroni, Elisa Grifoni, et al.
Journal of Thrombosis and Thrombolysis|February 17, 2010
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolismDaniela Poli, Elisa Grifoni, Emilia Antonucci, et al.
Pageof 27

Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
Annals of the Rheumatic Diseases|August 6, 2020
Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou <i>et al</i>Alessandra Bettiol, Francesca Pregnolato, Savino Sciascia, et al.
Internal and Emergency Medicine|May 10, 2023
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and CharybdisAlice Lipari, Silvia Sorrentino, Carlo Tamburini, et al.
Rheumatology (Oxford, England)|February 9, 2021
Comment on: Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. ReplyAlessandra Bettiol, Irene Mattioli, Giacomo Emmi, et al.
Thrombosis and Haemostasis|January 13, 2017
Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trialsFrancesco Dentali, Nicola Mumoli, Domenico Prisco, et al.
Thrombosis and Haemostasis|May 1, 2009
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatmentDaniela Poli, Emilia Antonucci, Elisa Grifoni, et al.
Seminars in Thrombosis and Hemostasis|September 30, 2009
Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: an Italian experienceDomenico Prisco, Emilia Antonucci, Elisa Grifoni, et al.
Blood Reviews|April 14, 2015
Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of researchAlessandro Di Minno, Gaia Spadarella, Domenico Prisco, et al.
Internal and Emergency Medicine|December 29, 2023
Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditisDanilo Malandrino, Federica Bello, Giuseppe Lopalco, et al.
Journal of Thrombosis and Thrombolysis|October 19, 2019
Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic strokeVieri Vannucchi, Federico Moroni, Elisa Grifoni, et al.
Journal of Thrombosis and Thrombolysis|February 17, 2010
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolismDaniela Poli, Elisa Grifoni, Emilia Antonucci, et al.
Pageof 27